| 产品名称 | Imanis Life Sciences | CL180 | Nalm6-Fluc-Puro/CD19-KO |
|---|---|
| 目录号 | CL180 |
| 别名 | Nalm6-Fluc-Puro/CD19-KO |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| CL180 | 咨询 | 咨询 |
Imanis Life Sciences | CL180 | Nalm6-Fluc-Puro/CD19-KO
品名：Nalm6-Fluc-Puro/CD19-KO
货号：CL180
品牌：Imanis Life Sciences
产品描述
Species：Human
Cell Type：Pre-B Accute Lymphoblastic Leukemia
Transgene：Firefly luciferase (Fluc; Luc2)
Selection Gene：Puromycin resistance (Puro)
Nalm6-Fluc-Puro (Imanis #CL151) cells were transfected with Cas9-gRNA ribonucleoprotein complexes targeting human CD19. Individual cell clones were generated using a methylcellulose based semi-solid medium and screened for CD19 expression by flow cytometry. Sequencing of the targeted CD19 region confirmed genetic knock-out in the selected cell clone. This cell line has been tested for mycoplasma contamination and is certified mycoplasma free. The parental Nalm6 cell line was licensed and purchased directly from ATCC*. This cell line is also available for purchase as a pair with the Nalm6-Fluc-Puro (CD19 positive) cell line, for a discounted rate (link). *The ATCC trademark and trade name and any and all ATCC catalog numbers are trademarks of the American Type Culture Collection.
